about
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.SF3B1 mutations constitute a novel therapeutic target in breast cancer.Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines.Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort studyVinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study.Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta.Radical resection of a giant, invasive and symptomatic malignant Solitary Fibrous Tumour (SFT) of the pleura.Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison.Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue.Formalin fixation at low temperature better preserves nucleic acid integrity.miR-221/222 control luminal breast cancer tumor progression by regulating different targets.HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum.Efficiency of a preoperative axillary ultrasound and fine-needle aspiration cytology to detect patients with extensive axillary lymph node involvement.Search for neuro-endocrine markers (chromogranin A, synaptophysin and VGF) in breast cancers. An integrated approach using immunohistochemistry and gene expression profiling.Gene status in HER2 equivocal breast carcinomas: impact of distinct recommendations and contribution of a polymerase chain reaction-based method.Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer.Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyAdded value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer.Endothelial cell differentiation of human breast tumour stem/progenitor cells.A collection of primary tissue cultures of tumors from vacuum packed and cooled surgical specimens: a feasibility studyThe Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas?Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues.Underuse of anthracyclines in women with HER-2+ advanced breast cancer.Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology.Oxytocin and oxytocin receptors in cancer cells and proliferation.Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis.Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients.The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue.Glycerolized Reticular Dermis as a New Human Acellular Dermal Matrix: An Exploratory StudyHigh-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer.Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method."Giants in a Microcosm": Multinucleated Giant Cells Populating an Invasive Micropapillary Carcinoma of the Breast.A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancerUltrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer managementA "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors.
P50
Q27851787-52EC6BD9-7B85-40A5-A2B3-BDE6911EAA40Q27853097-DE6D7AE6-CD4C-4673-B9C4-621058A704CCQ30814926-5A12C173-A19C-4FF8-B586-532FE4DEEAEEQ33280166-03A6CBFE-1ACE-46AA-B2F0-1892268DD396Q33354783-F03791B8-B1ED-4C6F-848D-6C22F5AE0620Q33382202-211FD3E0-51AD-40A3-A9DE-BAF80443CD8FQ33382230-2DF46195-3780-45E1-9A7E-B8447ABC8684Q33528162-1BFBE679-39DB-46F7-832E-5F9268B5508CQ33579776-3F75B530-934F-4276-847F-C251F651DECAQ33649620-24D74017-1CC4-4931-9DC6-DC0FB0BC8CCCQ33941103-B7ED4161-3FBD-4781-93C9-A8187D9049D8Q33952998-121E3F8E-705B-4760-95D8-68E1DA02A093Q34118293-D4F85742-0D05-4AC5-8F8D-F4DAAFFD99CAQ34155779-5AEE4B04-0501-4637-92E6-66E5823E9CB5Q34160006-B33D3F84-0CD2-4C5A-8D6A-EDBAC4EE55D2Q34161862-7972AA8B-2333-4359-8012-4E6F05AE60F3Q34458036-8B89BC33-A426-412B-AFF7-90EFC9599D93Q34543264-82480E2A-DAF9-4172-8106-34FBA170069BQ34567461-ACA42969-FC7C-406C-AD9A-2C6FA409CE92Q34901466-7358EEEF-DA12-454E-9FD3-9AA541B1A187Q34919522-366AC2B9-C927-4822-AA27-9DA8F6AD7561Q35009961-98103527-52E2-4B32-B29F-3CFA43E97C72Q35218537-C4D35FC4-3117-473F-A0DD-A2D90009C191Q35395211-A834331A-7EDC-4A48-8148-4FCDE0C32616Q35496577-FBA10552-B372-4A58-AEF2-38776E1E1991Q35574950-BC9230DD-68F7-4152-B172-C635D7753803Q35584166-DC4BD60E-C208-475E-B122-0AD70B95AE55Q35587753-326D1F03-FC0A-4305-8FC2-7C8AD641BD4CQ35748058-E9C472AA-732A-4D34-9316-6B2B534AAE9FQ35762360-9DF257A8-E3AE-4106-96E8-A30E0242DFC5Q35881294-62BA1C43-15B3-4393-A59E-02CDAE736199Q35885771-A0A52D3C-3245-4C63-9D13-C8C89A6E8A55Q35893476-1C7BE8AF-E178-4012-B9C5-7829B298DD61Q35936848-DF623361-D3DC-4E34-A484-324F659CC3B5Q36061792-A8204E98-4597-4B0F-A9A9-6C5CBF900F23Q36246377-70F9D70F-7C90-4001-88CF-1603C2FC6AD0Q36266046-119C064C-7561-4177-A521-34257372AE42Q36616632-6CE85DF2-4D6D-42E7-9547-3D093750C7DDQ36646627-CEF10934-0ED1-4F11-8EFA-09BB8DBE0557Q36919406-EAC2C03F-6D00-45A7-B308-60B6C2087AFD
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anna Sapino
@ast
Anna Sapino
@en
Anna Sapino
@es
Anna Sapino
@nl
Anna Sapino
@sl
type
label
Anna Sapino
@ast
Anna Sapino
@en
Anna Sapino
@es
Anna Sapino
@nl
Anna Sapino
@sl
prefLabel
Anna Sapino
@ast
Anna Sapino
@en
Anna Sapino
@es
Anna Sapino
@nl
Anna Sapino
@sl
P106
P1153
7005772202
P21
P31
P496
0000-0003-3542-9571